LumiraDx Ltd. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2014

Location

London UK

Primary Industry

Medical Devices & Equipment

About

Based in London, UK, and founded in 2014, LumiraDx Ltd. operates as a healthcare company. The company was co-founded by CEO Ron Zwanziger, CSO Jerry McAleer, and Sumit Nagpal. As of April 2021, LumiraDx has raised a total of USD 700 million over its funding rounds. LumiraDx has developed its antigen test for COVID-19 on the LumiraDx Platform. The test is being used by the National Health Service (NHS) and Boots in the UK, CVS Health in the U.S., a significant number of accident and emergency rooms in Italy and other parts of Europe and is being deployed in partnership with the Bill and Melinda Gates Foundation in a growing number of African countries where access to laboratory diagnostics is limited. LumiraDx Platform also includes point-of-care tests for COVID-19 Antibody, INR, and D-Dimer lab-based tests are available in Europe. The company's platform is also designed to integrate the used assay technologies such as enzyme, immunoassay, molecular and electrolytes as well as sample types of testing such as a swab, saliva, and blood. In 2020, the company has earned over USD 139 million in revenue. LumiraDx plans to list its common shares and trade on Nasdaq under the LMDX ticker.

Current Investors

Bill & Melinda Gates Foundation, U.S. Boston Capital, Capital One

Request a demo to show more

Primary Industry

Medical Devices & Equipment

Sub Industries

Molecular Science, Genetics & Gene Therapy, Healthcare IT, Diagnostic Equipment, Medical Software

Website

www.lumiradx.com

Verticals

HealthTech

Company Stage

Mature

Total Amount Raised

Subscriber access only

Deals

Deals Type
PIPE

Deal Status	Target (s)	Deal Date	Investor(s)	Seller(s)	Deal size (Mn)	Enterprise value (Mn)	Post-money valuation (Mn)	EBITDA multiple (x)	Revenue multiple (x)	Lead partner (s)
Completed	LumiraDx Ltd.	20 Jul 2022

Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.